Background: Numerous free and low-cost mobile apps for the care management of kidney disease have become available in recent years. Although these appear to be promising tools, they have not been evaluated comparatively based on standard mobile app metrics, and thus, limited evidence is available regarding their efficacy. This study systematically cataloged and assessed mobile apps designed to assist medication compliance and nutrition tracking that are useful to the chronic kidney disease (CKD) and the end-stage renal disease (ESRD) patients who are on dialysis. Objective: The objective of this study was to comprehensively evaluate mobile apps used for medication compliance and nutrition tracking for possible use by CKD and ESRD patients. Methods: A systematic review framework was applied to the search, screening, and assessment of apps identified and downloaded from the iOS and Android app stores. We selected apps using 13 relevant search terms, narrowed down based on a set of inclusion and exclusion criteria, and then used the Mobile App Rating Scale (MARS), a widely adopted app evaluation tool to assess the effectiveness of apps. The internal consistency and interrater reliability were tested using Cronbach alpha and interclass correlation coefficients (ICCs), respectively. Results: The MARS total score had excellent internal consistency (Cronbach alpha=.90) and a moderate level of interrater reliability (2-way mixed ICC 0.65). Overall, 11 out of the 12 reviewed apps met the minimum acceptable score of 3.0 in MARS rating. The 3 apps with the highest combined scores were My Kidneys, My Health Handbook (MARS=4.68); My Food Coach (MARS=4.48); and National Kidney Foundation Malaysia (MARS=4.20). The study identified 2 general weaknesses in the existing apps: the apps fell short of accommodating advanced interactive features such as providing motivational feedback and promoting family member and caregiver participations in the app utilization. Conclusions: The MARS rating system performed well in the app evaluation. The 3 highest ranked apps scored consistently high across the 5 dimensions specified in MARS. These apps were developed in collaboration with reputable organizations and field experts, demonstrating the importance of expert guidance in developing medical apps.
24 October 2007 in Biological Trace Element Research
Introduction Living-donor kidney transplantation is the gold standard treatment for patients with end-stage kidney disease. However, potential donors ubiquitously face financial as well as logistical barriers. To remove these disincentives from living kidney donations, the governments of 23 countries have implemented reimbursement programmes that shift the burdens of non-medical costs from donors to the governments or private entities. However, scientific evidence for the effectiveness of these programmes is scarce. The present study investigates whether these reimbursement programmes designed to ease the financial and logistical barriers succeeded in increasing the number of living kidney donations at the country level. The study examined within-country variations in the timing of such reimbursement programmes. Method The study applied the difference-in-difference (two-way panel fixed-effect) technique on the Poisson distribution to estimate the effects of these reimbursement programmes on a 17 year long (2000–2016) dataset covering 109 countries where living donor kidney transplants were performed. Results The results indicated that reimbursement programmes have a statistically significant positive effect. Overall, the model predicted that reimbursement programmes increased country-level donation numbers by a factor of 1.12–1.16. Conclusion Reimbursement programmes may be an effective approach to alleviate the kidney shortage worldwide. Further analysis is warranted on the type of reimbursement programmes and the ethical dimension of each type of such programmes.
Naoru Koizumi, Abu Bakkar Siddique, Ali Andalibi; Assessment of SARS-CoV-2 Transmission Among Attendees of Live Concert Events in Japan Using Contact Tracing D
4 August 2009 in Administration and Policy in Mental Health and Mental Health Services Research
Background: Living kidney donation currently constitutes approximately a quarter of all kidney donations. There exist barriers that preclude prospective donors from donating, such as medical ineligibility and costs associated with donation. A better understanding of perceptions of and barriers to living donation could facilitate the development of effective policies, education opportunities, and outreach strategies and may lead to an increased number of living kidney donations. Prior research focused predominantly on perceptions and barriers among a small subset of individuals who had prior exposure to the donation process. The viewpoints of the general public have rarely been represented in prior research. Objective: The current study designed a web-scraping method and machine learning algorithms for collecting and classifying comments from a variety of online sources. The resultant data set was made available in the public domain to facilitate further investigation of this topic. Methods: We collected comments using Python-based web-scraping tools from the New York Times, YouTube, Twitter, and Reddit. We developed a set of guidelines for the creation of training data and manual classification of comments as either related to living organ donation or not. We then classified the remaining comments using deep learning. Results: A total of 203,219 unique comments were collected from the above sources. The deep neural network model had 84% accuracy in testing data. Further validation of predictions found an actual accuracy of 63%. The final database contained 11,027 comments classified as being related to living kidney donation. Conclusions: The current study lays the groundwork for more comprehensive analyses of perceptions, myths, and feelings about living kidney donation. Web-scraping and machine learning classifiers are effective methods to collect and examine opinions held by the general public on living kidney donation.